Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study)Research in context

Summary: Background: The only disease-modifying treatment currently available for allergic rhinitis (AR) is allergen immunotherapy (AIT). The main objective of the EfficAPSI real-world study (RWS) was to evaluate the impact of liquid sublingual immunotherapy (SLIT-liquid) on asthma onset and evolut...

全面介紹

書目詳細資料

發表在:	The Lancet Regional Health. Europe
Main Authors:	Pascal Demoly, Mathieu Molimard, Jean-François Bergmann, Bertrand Delaisi, Amandine Gouverneur, Jade Vadel, Cédric Collin, Laurence Girard, Silvia Scurati, Philippe Devillier
格式:	Article
語言:	英语
出版:	Elsevier 2024-06-01
主題:	Asthma Rhinitis Allergic Sublingual immunotherapy Precision medicine
在線閱讀:	http://www.sciencedirect.com/science/article/pii/S2666776224000826